Venture Capital
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
6 June 2022
Download
Press Release
Press Release
Download
Related News
Mérieux Innovation 2 invests in SRTD Biotech, a leading German biotechnology company
- Venture Capital
- Recent investments & divestments
Mérieux Innovation 2 invests in HighLife Medical, a leading French MedTech company
- Venture Capital
- Recent investments & divestments